Valuation : Haleon plc

Market Cap 32.58B 44.01B 37.96B 35.76B 60.9B 4,157B 61.36B 423B 164B 2,125B 165B 162B 6,982B P/E 2026 *
19.2x
P/E 2027 * 17.2x
Enterprise Value 39.46B 53.29B 45.98B 43.31B 73.76B 5,034B 74.31B 513B 199B 2,574B 200B 196B 8,455B EV / Sales 2026 *
3.46x
EV / Sales 2027 * 3.27x
Free-Float
98.46%
Yield 2026 *
2.18%
Yield 2027 * 2.42%

Last Transcript : Haleon plc

1 day-1.05%
1 week-0.97%
Current month-0.60%
1 month+0.74%
3 months+12.00%
6 months-9.79%
Current year-2.35%
1 week 361.7
Extreme 361.7
373.7
1 month 348.8
Extreme 348.8
374.6
Current year 317.8
Extreme 317.8
416.1
1 year 274.4
Extreme 274.4
416.1
3 years 274.4
Extreme 274.4
419.5
5 years 241.17
Extreme 241.1735
419.5
10 years 241.17
Extreme 241.1735
419.5
Manager TitleAgeSince
Chief Executive Officer 59 2021-07-21
Director of Finance/CFO 58 2024-10-31
Chief Tech/Sci/R&D Officer 63 2025-07-31
Director TitleAgeSince
Director/Board Member 59 2022-05-22
Chairman 71 2025-12-31
Director/Board Member 59 2022-07-17
Date Insider Type Main position Quantity % Market Cap. Importance
6/30/26 Free

Chief Financial Officer

283,193 0.0032%
6/30/26 Tax

Chief Financial Officer

-133,301 0.0015%
5/19/26 Others 4,415 0.0000% -
Change 5-day change 1-year change 3-year change Capi.($)
-1.05%-0.97%+1.47%+14.41% 44.08B
+0.01%-2.47%+57.79%+107.83% 1,034B
+1.48%+1.93%+54.56%+71.28% 654B
+0.67%-0.45%+23.50%+79.14% 459B
+0.49%-6.58%+34.20%+34.59% 343B
+0.27%+2.32%+29.33%+46.97% 307B
+0.12%-4.01%+1.06%+11.93% 251B
+1.08%+0.57%+54.34%+74.34% 237B
+2.64%-2.00%-17.38%-53.64% 202B
-0.21%+1.03%+32.74%+99.06% 186B
Average +0.58%-2.58%+27.16%+48.59% 371.57B
Weighted average by Cap. +0.66%-3.27%+38.41%+67.16%

Financials

2026 *2027 *
Net sales 11.39B 15.38B 13.27B 12.5B 21.29B 1,453B 21.45B 148B 57.43B 743B 57.76B 56.49B 2,440B 11.86B 16.02B 13.82B 13.02B 22.18B 1,514B 22.34B 154B 59.83B 774B 60.17B 58.86B 2,542B
Net income 1.7B 2.3B 1.98B 1.87B 3.18B 217B 3.2B 22.09B 8.57B 111B 8.62B 8.43B 364B 1.91B 2.57B 2.22B 2.09B 3.56B 243B 3.59B 24.76B 9.61B 124B 9.66B 9.45B 408B
Net Debt 6.88B 9.29B 8.01B 7.55B 12.85B 877B 12.95B 89.35B 34.68B 449B 34.87B 34.11B 1,473B 6.22B 8.41B 7.25B 6.83B 11.63B 794B 11.72B 80.88B 31.39B 406B 31.57B 30.88B 1,334B
Logo Haleon plc
Haleon plc specializes in the research, manufacture and marketing of drugs and consumer pharmaceutical products. Net sales break down by family of products as follows: - oral health products (31.4%; no. 1 worldwide): Sensodyne, Parodontax, Polident, Biotene, Aquafresh brands, etc.; - pain relief medicines (23.2%; no. 1 worldwide): Panadol, Advil, Voltaren, Excedrin brands, etc.; - respiratory medicines (17%; no. 1 worldwide): Theraflu, Otrivin, Flonase, Contac brands, etc.; - vitamins, minerals and food supplements (15.3%; no. 1 worldwide): Centrum, Emergen-C, Caltrate brands, etc.; - medicines for digestive health (8.9%; no. 1 worldwide): TUMS, Nicorette, ENO, Chap Stick, Fenistil, Nexium brands, etc.; - other (4.2%). Net sales are distributed geographically as follows: Europe/Middle East/Africa/Latin America (41.6%), North America (35.1%), and Asia/Pacific (23.3%).
Employees
24,535
Date Price Change Volume
26-09-02 GBX 366.00 -1.05% 17,139,146
26-09-01 GBX 369.90 +0.46% 25,449,301
26-08-28 GBX 368.20 -0.35% 18,171,868
26-08-27 GBX 369.50 -1.02% 17,908,866
26-08-26 GBX 373.30 +1.00% 18,446,563
Trader
Investor
Global
Quality
ESG MSCI
AA
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
18
Last Close Price
3.699GBP
Average target price
4.211GBP
Spread / Average Target
+13.85%

Quarterly revenue - Rate of surprise